KC Investment Advisors LLC Acquires 124 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

KC Investment Advisors LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,634 shares of the healthcare conglomerate’s stock after purchasing an additional 124 shares during the quarter. UnitedHealth Group accounts for approximately 1.2% of KC Investment Advisors LLC’s portfolio, making the stock its 15th largest position. KC Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,455,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Jennison Associates LLC boosted its holdings in shares of UnitedHealth Group by 205.8% in the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock worth $779,944,000 after buying an additional 1,310,783 shares during the last quarter. Fiera Capital Corp boosted its holdings in shares of UnitedHealth Group by 99.5% in the 1st quarter. Fiera Capital Corp now owns 2,137,018 shares of the healthcare conglomerate’s stock worth $795,120,000 after buying an additional 1,065,868 shares during the last quarter. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 5.8% in the 1st quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock worth $7,032,097,000 after buying an additional 1,040,094 shares during the last quarter. Lazard Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 185.4% in the 1st quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock worth $438,545,000 after buying an additional 765,729 shares during the last quarter. Finally, Ontario Teachers Pension Plan Board purchased a new position in shares of UnitedHealth Group in the 1st quarter worth about $266,424,000. Hedge funds and other institutional investors own 86.21% of the company’s stock.

In other news, Director Stephen J. Hemsley sold 60,000 shares of the stock in a transaction that occurred on Friday, July 16th. The stock was sold at an average price of $420.62, for a total transaction of $25,237,200.00. Following the completion of the sale, the director now owns 941,560 shares of the company’s stock, valued at $396,038,967.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Friday, September 17th. The shares were sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. Insiders have sold 101,438 shares of company stock worth $42,396,929 over the last quarter. Company insiders own 0.55% of the company’s stock.

UNH has been the topic of several recent research reports. Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $430.00 to $462.00 and gave the company an “outperform” rating in a report on Friday, July 16th. Citigroup upped their price objective on shares of UnitedHealth Group from $450.00 to $480.00 and gave the company a “buy” rating in a report on Friday, July 16th. Barclays upped their price objective on shares of UnitedHealth Group from $435.00 to $465.00 and gave the company an “overweight” rating in a report on Friday, July 16th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $515.00 to $488.00 and set an “overweight” rating on the stock in a report on Tuesday, August 31st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $418.00 to $421.00 and gave the company a “buy” rating in a report on Tuesday, July 13th. Three investment analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $447.79.

Shares of UNH stock traded up $2.20 during trading on Monday, hitting $409.28. The company had a trading volume of 64,181 shares, compared to its average volume of 2,981,083. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.62. The stock’s 50-day moving average is $415.77 and its two-hundred day moving average is $402.29. The stock has a market capitalization of $385.92 billion, a price-to-earnings ratio of 26.89, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a 52 week low of $291.22 and a 52 week high of $431.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.43 by $0.27. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. The business had revenue of $71.32 billion for the quarter, compared to analysts’ expectations of $69.51 billion. During the same period last year, the business earned $7.12 earnings per share. The business’s quarterly revenue was up 14.8% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th were given a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date was Friday, September 10th. UnitedHealth Group’s payout ratio is currently 34.36%.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: What is the QQQ ETF?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.